ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
청신경초종 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 7.7%로 26억 5,000만 달러로 성장합니다. 예측 기간의 성장은 기술 발전, 맞춤형 의료, 의료비 지출 증가, 환자 선호도 및 요구, 의료 인프라 개발 등에 기인합니다. 예측 기간의 주요 동향으로는 발병률 증가, 기술 혁신, 시장 확대, 공동 연구 구상, 치료 방법의 발전 등이 있습니다.
향후 5년간 7.7%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세로 인해 독일과 네덜란드에서 수입되는 고급 MRI 코일과 청력 측정 장비의 가격이 상승하고 진단이 지연되고 의료비 지출이 증가함에 따라 미국의 의료용 영상 처리 부문은 후퇴에 직면할 수 있습니다. 또한 상호 관세와 무역 마찰 및 제한 강화로 인한 세계 경제 및 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
의료 분야에 대한 투자가 급증하면서 청신경초종 시장의 성장을 가속할 것으로 예측됩니다. 의료 부문은 건강 증진, 의료 서비스 제공, 개인 및 집단의 전반적인 행복 증진을 목적으로 하는 다양한 서비스와 시설을 포괄합니다. 의료에 대한 투자 증가는 수요 증가, 기술 혁신, 규제 변화, 세계 보건 이슈 등 다양한 요인에 의해 촉진되고 있습니다. 이러한 투자는 청신경초종과 같은 질환의 진단과 치료의 진보를 지원하고, 궁극적으로 환자의 예후와 삶의 질을 향상시킬 수 있습니다. 예를 들어 2023년 12월 메디케어-메디케이드 서비스 센터(CMS)의 데이터에 따르면 2022년 미국의 의료비 지출은 4.1% 증가하여 총 4조 5,000억 달러에 달할 것으로 예측됩니다. 그 결과, 의료 분야에 대한 투자 확대가 청신경초종 시장 확대에 박차를 가하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장의 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·Covid와 회복이 시장에 미치는 영향을 포함한다
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 청신경초종시장 : PESTEL 분석(정치·사회·기술·환경·법적 요인, 촉진요인, 억제요인)
최종 용도 산업의 분석
세계의 청신경초종시장 : 성장률 분석
세계의 청신경초종 시장 규모·성장률 : 실적(2019-2024년)
세계의 청신경초종 시장 규모·성장률 : 예측(2024-2029년, 2034년)
세계의 청신경초종시장 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 청신경초종시장 : 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
편측성 전정 신경초종
양측성 전정 신경초종
세계의 청신경초종시장 : 치료 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
약물
항경련약
방사선 치료
양자선 치료
정위방사선 수술
세계의 청신경초종시장 : 진단 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
자기공명영상(MRI)
컴퓨터 단층촬영 스캔(CT 스캔)
청력 검사
세계의 청신경초종시장 : 최종사용자별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
외과 센터
세계의 청신경초종시장 : 편측성 전정 신경초종 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
소형 편측성 전정 신경초종 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
중형 편측성 전정 신경초종 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
대형 편측성 전정 신경초종 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
양측성 전정 신경초종 기타 변이 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
제7장 지역별·국가별 분석
세계의 청신경초종시장 : 지역별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
세계의 청신경초종시장 : 국가별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
청신경초종시장 : 경쟁 구도
청신경초종시장 : 기업 개요
Pfizer Inc(개요, 제품·서비스, 전략, 재무 분석)
F. Hoffmann-La Roche AG(개요, 제품·서비스, 전략, 재무 분석)
General Electric Company(개요, 제품·서비스, 전략, 재무 분석)
Merck & Co. Inc.(개요, 제품·서비스, 전략, 재무 분석)
Sanofi S.A.(개요, 제품·서비스, 전략, 재무 분석)
제31장 기타 대기업과 혁신적 기업
AstraZeneca plc
Abbott Laboratories
Novartis AG
GSK plc
Medtronic plc
Canon Medical Systems Corporation
Toshiba Medical Systems Corporation
Amgen Inc.
Siemens Healthineers
Teva Pharmaceuticals Industries Ltd
Olympus Corporation
Shimadzu Corporation
Varian Medical Systems
Elekta AB
Cochlear Limited
제32장 세계 시장 : 경쟁 벤치마킹·대시보드
제33장 주요 기업인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력의 높은 국가·부문과 전략
청신경초종시장 : 최신 기회를 제공하는 국가(2029년)
청신경초종시장 : 최신 기회를 제공하는 부문(2029년)
청신경초종시장 : 성장 전략(2029년)
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSA
영문 목차
영문목차
Acoustic neuroma, also known as vestibular schwannoma, is a benign tumor that develops on the vestibular nerve, linking the inner ear to the brain and responsible for transmitting balance and hearing information. These tumors typically progress slowly and remain confined to their original location, manifesting symptoms such as hearing loss, tinnitus (ringing in the ear), dizziness, imbalance, facial numbness or weakness, and coordination difficulties.
The primary types of acoustic neuroma include unilateral vestibular schwannomas and bilateral vestibular schwannomas. Unilateral vestibular schwannomas refer to tumors that develop on one side of the vestibulocochlear nerve, affecting both hearing and balance functions. Treatment options encompass medications, anticonvulsants, radiation therapy, proton therapy, and stereotactic radiosurgery. Diagnosis typically involves magnetic resonance imaging (MRI), computed tomography scan (CT-scan), and hearing tests. End users involved in the management of acoustic neuroma include hospitals, clinics, and surgical centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The acoustic neuroma market research report is one of a series of new reports from The Business Research Company that provides acoustic neuroma market statistics, including acoustic neuroma industry global market size, regional shares, competitors with a acoustic neuroma market share, detailed acoustic neuroma market segments, market trends and opportunities, and any further data you may need to thrive in the acoustic neuroma industry. This acoustic neuroma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The acoustic neuroma market size has grown strongly in recent years. It will grow from $1.83 billion in 2024 to $1.97 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to advancements in imaging technologies, surgical innovations, increased awareness and screening programs, economic factors, and regulatory approvals.
The acoustic neuroma market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to technological advancements, personalized medicine, rising healthcare spending, patient preferences and demands, and healthcare infrastructure development. Major trends in the forecast period include increasing incidence rates, technological innovations, market expansion, collaborative research initiatives, and advancements in treatment modalities.
The forecast of 7.7% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. medical imaging sector could face setbacks as tariffs raise the price of advanced MRI coils and audiometric equipment imported from Germany and the Netherlands, delaying diagnoses and increasing healthcare expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The surge in investment in the healthcare sector is anticipated to drive the growth of the acoustic neuroma market. The healthcare sector encompasses a broad range of services and facilities aimed at promoting health, providing medical care, and improving overall well-being for individuals and populations. Increased investment in healthcare is driven by various factors, including rising demand, technological innovation, regulatory changes, and global health challenges. These investments support advancements in diagnostics and treatments for conditions such as acoustic neuroma, ultimately enhancing patient outcomes and quality of life. For example, data from the Centers for Medicare & Medicaid Services (CMS) in December 2023 indicated a 4.1% increase in healthcare spending in the U.S. in 2022, reaching a total of $4.5 trillion. Consequently, the growing investment in the healthcare sector is fueling the expansion of the acoustic neuroma market.
Key players in the acoustic neuroma market are focusing on developing innovative treatment options, particularly radiosurgery methods tailored for acoustic neuroma patients, to offer enhanced features and benefits. Radiosurgery methods for acoustic neuroma involve precisely delivering radiation to the tumor to destroy or shrink it while minimizing damage to surrounding healthy tissue. For instance, Elekta, a Swedish-based medical technology company, introduced Elekta Esprit in May 2022, an advanced radiosurgery system designed for high-precision stereotactic radiosurgery targeting brain tumors, vascular malformations, or functional disorders. Elekta Esprit provides clinicians with faster automated treatment planning, enabling more personalized and patient-friendly treatments with exceptional precision. This advanced system offers superior visualization, remote accessibility, and collaboration tools, allowing treatment teams to address even the most challenging targets with exceptional accuracy while ensuring a gentle, personalized approach to radiosurgery.
In December 2022, Eli Lilly and Company, a US-based pharmaceutical company, acquired Akouos, Inc. for approximately $487 million. This acquisition aligns with Lilly's strategic focus on expanding its genetic medicines portfolio and enhances its capabilities in adeno-associated viral gene therapies. Specifically, the acquisition strengthens Lilly's efforts to develop treatments for inner ear conditions, including sensorineural hearing loss. Akouos, Inc. is a US-based biotechnology company specializing in pioneering gene therapies for hearing-related disorders, making this acquisition an important step for Lilly in advancing its position in the emerging field of genetic treatments for hearing impairments.
Major companies operating in the acoustic neuroma market are Pfizer Inc, F. Hoffmann-La Roche AG, General Electric Company, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GSK plc, Medtronic plc, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation, Amgen Inc., Siemens Healthineers, Teva Pharmaceuticals Industries Ltd, Olympus Corporation, Shimadzu Corporation, Varian Medical Systems, Elekta AB, Cochlear Limited, Brainlab AG, Natus Medical Incorporated, CIVCO Medical Solutions, Monteris Medical, BrainScope Company Inc.
North America was the largest region in the acoustic neuroma market in 2024. The regions covered in the acoustic neuroma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the acoustic neuroma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The acoustic neuroma market consists of revenues earned by entities by providing services such as neurosurgery, hearing tests, auditory rehabilitation, and counseling and support services for patients and families. The market value includes the value of related goods sold by the service provider or included within the service offering. The acoustic neuroma market also includes sales of hearing aids, surgical instruments, balance therapy equipment, and assistive listening devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Acoustic Neuroma Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on acoustic neuroma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for acoustic neuroma ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acoustic neuroma market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Unilateral Vestibular Schwannomas; Bilateral Vestibular Schwannomas
4) By End User: Hospitals; Clinics; Surgical Centers
Subsegments:
1) By Unilateral Vestibular Schwannomas: Small Unilateral Vestibular Schwannomas; Medium Unilateral Vestibular Schwannomas; Large Unilateral Vestibular Schwannomas; Malignant Unilateral Vestibular Schwannomas; Other Variants Of Unilateral Vestibular Schwannomas
2) By Bilateral Vestibular Schwannomas: Familial Bilateral Vestibular Schwannomas; Sporadic Bilateral Vestibular Schwannomas; Other Variants Of Bilateral Vestibular Schwannomas
Companies Mentioned: Pfizer Inc; F. Hoffmann-La Roche AG; General Electric Company; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca plc; Abbott Laboratories; Novartis AG; GSK plc; Medtronic plc; Canon Medical Systems Corporation; Toshiba Medical Systems Corporation; Amgen Inc.; Siemens Healthineers; Teva Pharmaceuticals Industries Ltd; Olympus Corporation; Shimadzu Corporation; Varian Medical Systems; Elekta AB; Cochlear Limited; Brainlab AG; Natus Medical Incorporated; CIVCO Medical Solutions; Monteris Medical; BrainScope Company Inc
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Acoustic Neuroma Market Characteristics
3. Acoustic Neuroma Market Trends And Strategies
4. Acoustic Neuroma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Acoustic Neuroma Growth Analysis And Strategic Analysis Framework
5.1. Global Acoustic Neuroma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Acoustic Neuroma Market Growth Rate Analysis
5.4. Global Acoustic Neuroma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Acoustic Neuroma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Acoustic Neuroma Total Addressable Market (TAM)
6. Acoustic Neuroma Market Segmentation
6.1. Global Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Unilateral Vestibular Schwannomas
Bilateral Vestibular Schwannomas
6.2. Global Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drugs
Anticonvulsants
Radiation Therapy
Proton Therapy
Stereotactic Radiosurgery
6.3. Global Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Magnetic Resonance Imaging (MRI)
Computed Tomography Scan (CT-SCAN)
Hearing Tests
6.4. Global Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Surgical Centers
6.5. Global Acoustic Neuroma Market, Sub-Segmentation Of Unilateral Vestibular Schwannomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Unilateral Vestibular Schwannomas
Medium Unilateral Vestibular Schwannomas
Large Unilateral Vestibular Schwannomas
Malignant Unilateral Vestibular Schwannomas
Other Variants Of Unilateral Vestibular Schwannomas
6.6. Global Acoustic Neuroma Market, Sub-Segmentation Of Bilateral Vestibular Schwannomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Familial Bilateral Vestibular Schwannomas
Sporadic Bilateral Vestibular Schwannomas
Other Variants Of Bilateral Vestibular Schwannomas
7. Acoustic Neuroma Market Regional And Country Analysis
7.1. Global Acoustic Neuroma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Acoustic Neuroma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
